Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder
Phase 3
Completed
- Conditions
- Borderline Personality Disorder
- Interventions
- Drug: Placebo (for Selegiline)
- First Posted Date
- 2013-07-31
- Last Posted Date
- 2015-10-08
- Lead Sponsor
- Mood and Anxiety Research, Inc
- Target Recruit Count
- 30
- Registration Number
- NCT01912391
- Locations
- 🇺🇸
Mood and Anxiety Research, Inc, Fresno, California, United States
News
No news found